Respiratory Health

Respiratory conditions can produce symptoms that are hard on patients and challenging to diagnose without accurate and timely diagnostic information. True Health offers a comprehensive respiratory pathogen screen by nasopharyngeal swab to help clinicians identify key viral and bacterial targets, and translate results into quick, accurate treatment.

Key Benefits



Get Started

Adults average 2 to 4 upper respiratory tract infections each year, and children average 6 to 8.1

Acute respiratory infections are the most common reason for antibiotic prescriptions in adults, comprising 41% of all antibiotic prescriptions.2

Benefits of Respiratory Testing

  • Reduces diagnosis time 3

  • Enables improved patient management 4

  • Results in shorter duration of antibiotic use3,5

  • Leads to shorter hospital stays3,5

21 Common Respiratory Pathogens in One Test

Viral Targets
  • Adenovirus
  • Coronavirus HKU1
  • Coronavirus NL63
  • Coronavirus 229E
  • Coronavirus OC43
  • Human Metapneumovirus
  • Human Rhinovirus/Enterovirus
  • Influenza A, including subtypes: A/H1, A/H3, A/H1-2009
  • Influenza B
  • Parainfluenza Virus 1
  • Parainfluenza Virus 2
  • Parainfluenza Virus 3
  • Parainfluenza Virus 4
  • Respiratory Syncytial Virus
Bacterial Targets
  • Bordetella parapertussis (IS1001)
  • Bordetella pertussis (ptxP)
  • Chlamydia pneumonia
  • Mycoplasma pneumonia

Taking Action

The right prescription for the right diagnosis.

Antibiotics can be an effective tool for managing infection, but only if clinicians have all of the information they need for an accurate diagnosis. An estimated 50% of antibiotic prescriptions for Acute Respiratory Tract Infections are unnecessary, contributing to antibiotic resistance.6 Antibiotic resistance can increase mortality and morbidity from untreatable diseases, increase risk of global spread of pathogens, and result in longer, more frequent hospital stays.

True Health’s Respiratory Pathogen Screen delivers key benefits to help clinicians avoid unnecessary antibiotics and prescribe effective medication. Our CLIA-and-CAP-certified testing delivers key benefits that point-of-care testing may miss:

Improved Clarity of Results

Increased Sensitivity

Fewer Equivocal Results

Get Started

Clinicians: Order supplies for the Respiratory Pathogen Screen or request a new account.

Send me supplies to begin ordering the Respiratory Pathogen Screen when medically necessary.
I am a clinician, and would like to request a new True Health account to begin ordering the Respiratory Pathogen Screen when medically necessary.I am NOT a clinician, and I have a question about True Health’s Respiratory Pathogen Screen.

Learn more about True Health’s Respiratory Pathogen Screen

Contact your True Health Representative, or call us at 1.877.433.5227.

  1. Upper Respiratory Infection (URI or Common Cold).,P02966. Accessed October 30, 2017.
  2. Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American college of physicians and the centers for disease control and prevention. Annals of Internal Medicine. 2016;164, 425-34. Accessed October 30, 2017.
  3. Rappo U, et al. Impact of early detection of respiratory viruses by multiplex PCR assay on clinical outcomes in adult patients. J Clin Microbiol. 2016; 54(8):2096-103.
  4. Xu M, et al. Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround and patient care. Am J Clin Pathol. 2013; 139(1): 118-23.
  5. Rogers BB, et al. Impact of a Rapid Respiratory Panel Test on Patient Outcomes. Arch Pathol Lab Med. 2015;139:636–641.
  6. Fleming-Dutra KE, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA. 2016; 315(17):1866-73.